PHASE II CLINICAL TRIALS--N-(4-HDROXYPHENYL) RETINAMIDE

$0N01FY2000CNNIH

Southwest Oncology Group, San Antonio TX

Investigators

Charles A Coltman

View original record on NIH RePORTER →